Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multidisciplinary analysis of evolution based Abiraterone treatment for metastatic castrate resistant prostate cancer

medRxiv(2021)10.1101/2021.11.30.21267059Source: DataRank Database

Multidisciplinary analysis of evolution based Abiraterone treatment for metastatic castrate resistant prostate cancer is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (19)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jessica J. Cunningham ORCID,Joel S. Brown ORCID,Robert A. Gatenby ORCID,Jingsong Zhang ORCID

Live enrichment

PubMed:19276002 OpenAlex:https://openalex.org/W3215899255

European Commission

Grant: 690817

Conflict, Competition, Cooperation and Complexity: Using Evolutionary Game Theory to model realistic populations

National Institutes of Health

Grant: 5U54CA143970-05

Escape from Homeostasis: Integrated Mathmatical and Experimental Investigation

National Institutes of Health

Grant: 1R01CA170595-01

Application of Evolutionary Principles to Maintain Cancer Control (PQ21)

National Institutes of Health

Grant: 3P30CA076292-24S2

Moffitt Cancer Center Support Grant

green

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/12/02/2021.11.30.21267059.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.11.30.21267059

repositoryhttps://doi.org/10.1101/2021.11.30.21267059

https://dx.doi.org/10.1101/2021.11.30.21267059

Fields of Study

Prostate Cancer Treatment and ResearchCancer Genomics and DiagnosticsMultiple Myeloma Research and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineClinical trialPrednisoneProstate cancerDosingCohortAbiraterone acetateEnzalutamideAbirateroneOncologyInternal medicineCancerAndrogen deprivation therapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Multidisciplinary analysis of evolution based Abiraterone treatment for metastatic castrate resistant prostate cancer

FAIR Checklist

Authors (4)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)